A new immuno-, dystrophin-deficient model, the NSG-mdx4Cv mouse, provides evidence for functional improvement following allogeneic satellite cell transplantation

Stem Cells

Volumn 31, Issue 8, 2013, Pages 1611-1620

  Arpke, Robert W ^a   Darabi, Radbod ^a   Mader, Tara L ^b   Zhang, Yu ^a   Toyama, Akira ^a   Lonetree, Cara Lin ^a   Nash, Nardina ^a   Lowe, Dawn A ^b   Perlingeiro, Rita C R ^a   Kyba, Michael ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Dmd; Mdx; Muscular dystrophy; Satellite cells; Transplantation

Indexed keywords

CREATINE KINASE; DYSTROPHIN;

ALLOGENEIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DMD GENE; DOG; ENZYME ACTIVITY; FEMALE; GENE; HINDLIMB; MALE; MONONUCLEAR CELL; MOUSE; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE REGENERATION; MUSCLE STRENGTH; MUSCULAR DYSTROPHY; NONHUMAN; SATELLITE CELL; SWINE; X CHROMOSOME;

DMD; MDX; MUSCULAR DYSTROPHY; SATELLITE CELLS; TRANSPLANTATION;

ANIMALS; DISEASE MODELS, ANIMAL; DOGS; DYSTROPHIN; FEMALE; GENOTYPE; HETEROGRAFTS; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED NOD; MICE, SCID; MUSCULAR DYSTROPHY, DUCHENNE; SATELLITE CELLS, SKELETAL MUSCLE; STEM CELL TRANSPLANTATION; SWINE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84877261357     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.1402     Document Type: Article

References (36)

1. Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961;9:493-495.
2. Bischoff R. Proliferation of muscle satellite cells on intact myofibers in culture. Dev Biol 1986;115:129-139.
3. Seale P, Sabourin LA, Girgis-Gabardo A et al. Pax7 is required for the specification of myogenic satellite cells. Cell 2000;102:777-786.
4. Beauchamp JR, Heslop L, Yu DS et al. Expression of CD34 and Myf5 defines the majority of quiescent adult skeletal muscle satellite cells. J Cell Biol 2000;151:1221-1234.
5. Cornelison DD, Filla MS, Stanley HM et al. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration. Dev Biol 2001;239:79-94.
6. Sherwood RI, Christensen JL, Conboy IM et al. Isolation of adult mouse myogenic progenitors: Functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004;119:543-554.
7. Collins CA, Olsen I, Zammit PS et al. Stem cell function, selfrenewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche. Cell 2005;122:289-301.
8. Montarras D, Morgan J, Collins C et al. Direct isolation of satellite cells for skeletal muscle regeneration. Science 2005;309:2064-2067.
9. Sacco A, Doyonnas R, Kraft P et al. Self-renewal and expansion of single transplanted muscle stem cells. Nature 2008;456:502-506.
10. Bulfield G, Siller WG, Wight PA et al. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc Natl Acad Sci USA 1984;81: 1189-1192.
11. Darabi R, Gehlbach K, Bachoo RM et al. Functional skeletal muscle regeneration from differentiating embryonic stem cells. Nat Med 2008;14:134-143.
12. Darabi R, Pan W, Bosnakovski D et al. Functional myogenic engraftment from mouse iPS Cells. Stem Cell Rev 2011;7:948-957.
13. Hall JK, Banks GB, Chamberlain JS et al. Prevention of muscle aging by myofiber-associated satellite cell transplantation. Sci Transl Med 2010;2:57raa83.
14. Cerletti M, Jurga S, Witczak CA et al. Highly efficient, functional engraftment of skeletal muscle stem cells in dystrophic muscles. Cell 2008;134:37-47.
15. Partridge T. Denominator problems in a muscle stem cell study? Cell 2008;135:997-998; author reply 998-999.
16. Fukada S, Miyagoe-Suzuki Y, Tsukihara H et al. Muscle regeneration by reconstitution with bone marrow or fetal liver cells from green fluorescent protein-gene transgenic mice. J Cell Sci 2002;115: 1285-1293.
17. Partridge TA, Morgan JE, Coulton GR et al. Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature 1989;337:176-179.
18. Traggiai E, Chicha L, Mazzucchelli L et al. Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 2004;304:104-107.
19. Liao NS, Bix M, Zijlstra M et al. MHC class I deficiency: Susceptibility to natural killer (NK) cells and impaired NK activity. Science 1991;253:199-202.
20. Rideout WM, Hochedlinger K, Kyba M et al. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 2002;109:17-27.
21. Kyba M, Perlingeiro RCR, Daley GQ. HoxB4 confers definitive lymphoid-myeloid engraftment potential on embryonic stem cell and yolk sac hematopoietic progenitors. Cell 2002;109:29-37.
22. Ashton-Miller JA, He Y, Kadhiresan VA et al. An apparatus to measure in vivo biomechanical behavior of dorsi- and plantarflexors of mouse ankle. J Appl Physiol 1992;72:1205-1211.
23. Baltgalvis KA, Call JA, Nikas JB et al. Effects of prednisolone on skeletal muscle contractility in mdx mice. Muscle Nerve 2009;40: 443-454.
24. Bosnakovski D, Xu Z, Li W et al. Prospective isolation of skeletal muscle stem cells with a Pax7 reporter. Stem Cells 2008;26:3194-3204.
25. Bosma GC, Custer RP, Bosma MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983;301:527-530.
26. Cao X, Shores EW, Hu-Li J et al. Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. Immunity 1995;2:223-238.
27. Chapman VM, Miller DR, Armstrong D et al. Recovery of induced mutations for X chromosome-linked muscular dystrophy in mice. Proc Natl Acad Sci USA 1989;86:1292-1296.
28. Im WB, Phelps SF, Copen EH et al. Differential expression of dystrophin isoforms in strains of mdx mice with different mutations. Hum Mol Genet 1996;5:1149-1153.
29. Hoffman EP, Morgan JE, Watkins SC et al. Somatic reversion/suppression of the mouse mdx phenotype in vivo. J Neurol Sci 1990;99: 9-25.
30. Danko I, Chapman V, Wolff JA. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy. Pediatr Res 1992;32:128-131.
31. Brooks SV. Rapid recovery following contraction-induced injury to in situ skeletal muscles in mdx mice. J Muscle Res Cell Motil 1998;19: 179-187.
32. Call JA, Eckhoff MD, Baltgalvis KA et al. Adaptive strength gains in dystrophic muscle exposed to repeated bouts of eccentric contraction. J Appl Physiol 2011;111:1768-1777.
33. Morgan JE, Fletcher RM, Partridge TA. Yields of muscle from myogenic cells implanted into young and old mdx hosts. Muscle Nerve 1996;19:132-139.
34. Shultz LD, Lyons BL, Burzenski LM et al. Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 2005;174:6477-6489.
35. Trebbin AL, Hoey AJ. A novel and simple method for genotyping the mdx mouse using high-resolution melt polymerase chain reaction. Muscle Nerve 2009;39:603-608.
36. Banks GB, Combs AC, Chamberlain JS. Sequencing protocols to genotype mdx, mdx(4cv), and mdx(5cv) mice. Muscle Nerve 2010;42: 268-270.